The independent medical news service
27-04-2022 | Oncology | News | Article
Neurologic AE risk lower with ICIs vs chemotherapy
The risk for neurologic adverse events is significantly lower with immune checkpoint inhibitors than with other cancer treatments, particularly chemotherapy, suggest results of a systematic review and meta-analysis.